Societal CDMO Inc (DELISTED) (SCTL:DL)
1.10
0.00 (0.00%)
USD |
NASDAQ |
Apr 08, 16:00
Societal CDMO Revenue (Quarterly): 27.72M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 27.72M |
| September 30, 2023 | 23.59M |
| June 30, 2023 | 21.80M |
| March 31, 2023 | 21.53M |
| December 31, 2022 | 24.28M |
| September 30, 2022 | 21.59M |
| June 30, 2022 | 23.15M |
| March 31, 2022 | 21.19M |
| December 31, 2021 | 22.30M |
| September 30, 2021 | 18.24M |
| June 30, 2021 | 18.02M |
| March 31, 2021 | 16.80M |
| December 31, 2020 | 9.913M |
| September 30, 2020 | 19.29M |
| June 30, 2020 | 15.52M |
| March 31, 2020 | 21.78M |
| December 31, 2019 | 17.64M |
| September 30, 2019 | 25.26M |
| Date | Value |
|---|---|
| June 30, 2019 | 31.26M |
| March 31, 2019 | 25.06M |
| December 31, 2018 | 17.78M |
| September 30, 2018 | 18.28M |
| June 30, 2018 | 21.74M |
| March 31, 2018 | 19.54M |
| December 31, 2017 | 19.04M |
| September 30, 2017 | 17.11M |
| June 30, 2017 | 16.93M |
| March 31, 2017 | 18.74M |
| December 31, 2016 | 17.36M |
| September 30, 2016 | 16.95M |
| June 30, 2016 | 17.28M |
| March 31, 2016 | 17.74M |
| December 31, 2015 | 16.75M |
| September 30, 2015 | 16.54M |
| June 30, 2015 | 18.66M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
9.913M
Minimum
Dec 2020
31.26M
Maximum
Jun 2019
21.10M
Average
21.59M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| XOMA Corp | 1.833M |
| Ironwood Pharmaceuticals Inc | 117.55M |
| CymaBay Therapeutics Inc (DELISTED) | 0.057M |
| Homology Medicines Inc (DELISTED) | -- |
| Amgen Inc | 7.447B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.786M |
| Total Expenses (Quarterly) | 25.97M |
| Enterprise Value | 145.26M |
| Gross Profit Margin (Quarterly) | 27.77% |
| Profit Margin (Quarterly) | -2.84% |
| Earnings Yield | -13.64% |
| Normalized Earnings Yield | -13.64 |